Notice of Republication
This article was republished on December 3, 2024, to address an issue identified post-publication. Please download this article again to view the correct version.
The article’s Data Availability statement is updated to: The data are pseudonymised, meaning that the key variable may not be destroyed. According to Swedish ethics regulations, the raw data cannot be shared without an approved ethics application from the National Swedish Ethics Authority. An ethical permit can only be obtained for research being conducted within Sweden. Data requests can be emailed to forskningsdata@oru.se.
Reference
- 1. König J, Roca Rubio MF, Forsgård RA, Rode J, Axelsson J, Grompone G, et al. (2024) The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D—An exploratory RCT. PLoS ONE 19(11): e0312464. https://doi.org/10.1371/journal.pone.0312464 pmid:39485760
Citation: The PLOS ONE Editors (2025) Correction: The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D—An exploratory RCT. PLoS ONE 20(2): e0316404. https://doi.org/10.1371/journal.pone.0316404
Published: February 21, 2025
Copyright: © 2025 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.